Literature DB >> 18793164

Adipose tissue expandability: the metabolic problems of obesity may arise from the inability to become more obese.

Chong Yew Tan1, Antonio Vidal-Puig.   

Abstract

The prevalence of obesity is increasing and with it the prevalence of associated metabolic complications. Precisely how obesity results in metabolic disturbances remains unclear. In the face of persistent positive caloric balance, it has been postulated that the capacity of adipose tissue to safely store fat may be vital. This paper explores some of the evidence suggesting that the risk of developing metabolic disturbances is not related to how much fat an individual has, but how well their fat can expand to accommodate the caloric excess. If this is true, the metabolic consequences of obesity may arise from the inability to become more obese.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18793164     DOI: 10.1042/BST0360935

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  63 in total

1.  Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition.

Authors:  Hiroyuki Mori; Tyler C Prestwich; Michael A Reid; Kenneth A Longo; Isabelle Gerin; William P Cawthorn; Vedrana S Susulic; Venkatesh Krishnan; Andy Greenfield; Ormond A Macdougald
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

Review 2.  Obesity and related consequences to ageing.

Authors:  Magdalena Jura; Leslie P Kozak
Journal:  Age (Dordr)       Date:  2016-02-04

3.  Early B cell factor 1 regulates adipocyte morphology and lipolysis in white adipose tissue.

Authors:  Hui Gao; Niklas Mejhert; Jackie A Fretz; Erik Arner; Silvia Lorente-Cebrián; Anna Ehrlund; Karin Dahlman-Wright; Xiaowei Gong; Staffan Strömblad; Iyadh Douagi; Jurga Laurencikiene; Ingrid Dahlman; Carsten O Daub; Mikael Rydén; Mark C Horowitz; Peter Arner
Journal:  Cell Metab       Date:  2014-05-22       Impact factor: 27.287

4.  Psoas and paraspinous muscle index as a predictor of mortality in African American men with type 2 diabetes mellitus.

Authors:  Mariana Murea; Leon Lenchik; Thomas C Register; Gregory B Russell; Jianzhao Xu; S Carrie Smith; Donald W Bowden; Jasmin Divers; Barry I Freedman
Journal:  J Diabetes Complications       Date:  2018-03-19       Impact factor: 2.852

Review 5.  Adipocyte dysfunction, inflammation and metabolic syndrome.

Authors:  Nora Klöting; Matthias Blüher
Journal:  Rev Endocr Metab Disord       Date:  2014-12       Impact factor: 6.514

6.  Maternal prepregnancy waist circumference and BMI in relation to gestational weight gain and breastfeeding behavior: the CARDIA study.

Authors:  Helene Kirkegaard; Ellen A Nohr; Kathleen M Rasmussen; Henrik Stovring; Thorkild I A Sørensen; Cora E Lewis; Erica P Gunderson
Journal:  Am J Clin Nutr       Date:  2015-07-01       Impact factor: 7.045

Review 7.  'Metabolically healthy obesity': origins and implications.

Authors:  Gerald V Denis; Martin S Obin
Journal:  Mol Aspects Med       Date:  2012-10-13

8.  Deletion of the alpha-arrestin protein Txnip in mice promotes adiposity and adipogenesis while preserving insulin sensitivity.

Authors:  William A Chutkow; Andreas L Birkenfeld; Jonathan D Brown; Hui-Young Lee; David W Frederick; Jun Yoshioka; Parth Patwari; Romy Kursawe; Samuel W Cushman; Jorge Plutzky; Gerald I Shulman; Varman T Samuel; Richard T Lee
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

9.  Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57BL/6 mice.

Authors:  Caroline Duval; Uwe Thissen; Shohreh Keshtkar; Bertrand Accart; Rinke Stienstra; Mark V Boekschoten; Tania Roskams; Sander Kersten; Michael Müller
Journal:  Diabetes       Date:  2010-09-21       Impact factor: 9.461

10.  Increased hepatic oxidative metabolism distinguishes the action of Peroxisome proliferator-activated receptor delta from Peroxisome proliferator-activated receptor gamma in the ob/ob mouse.

Authors:  Lee D Roberts; David G Hassall; Deborah A Winegar; John N Haselden; Andrew W Nicholls; Julian L Griffin
Journal:  Genome Med       Date:  2009-12-07       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.